Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Days Sales Outstanding : 55.46 (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Days Sales Outstanding?

Santhera Pharmaceuticals Holding AG's average Accounts Receivable for the six months ended in Jun. 2023 was $1.33 Mil. Santhera Pharmaceuticals Holding AG's Revenue for the six months ended in Jun. 2023 was $4.38 Mil. Hence, Santhera Pharmaceuticals Holding AG's Days Sales Outstanding for the six months ended in Jun. 2023 was 55.46.

The historical rank and industry rank for Santhera Pharmaceuticals Holding AG's Days Sales Outstanding or its related term are showing as below:

SPHDF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.84 Med: 60.5 Max: 143.34
Current: 79.05

During the past 13 years, Santhera Pharmaceuticals Holding AG's highest Days Sales Outstanding was 143.34. The lowest was 25.84. And the median was 60.50.

SPHDF's Days Sales Outstanding is ranked worse than
54.44% of 889 companies
in the Biotechnology industry
Industry Median: 71.03 vs SPHDF: 79.05

Santhera Pharmaceuticals Holding AG's Days Sales Outstanding increased from Jun. 2022 (28.60) to Jun. 2023 (55.46).

Santhera Pharmaceuticals Holding AG Days Sales Outstanding Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Days Sales Outstanding Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

55.77

25.72

85.56

34.47

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial															105.12	-	28.60	100.35	55.46

Competitive Comparison of Santhera Pharmaceuticals Holding AG's Days Sales Outstanding

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santhera Pharmaceuticals Holding AG's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's Days Sales Outstanding falls into.

Santhera Pharmaceuticals Holding AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Santhera Pharmaceuticals Holding AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (1.045	+	0.47)	/	2 )	/	8.022	*	365
=	0.7575					/	8.022	*	365
=	34.47

Santhera Pharmaceuticals Holding AG's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.47	+	2.189)	/	2 )	/	4.375	*	365 / 2
=	1.3295					/	4.375	*	365 / 2
=	55.46

Santhera Pharmaceuticals Holding AG (OTCPK:SPHDF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Santhera Pharmaceuticals Holding AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Santhera Pharmaceuticals Holding AG (Santhera Pharmaceuticals Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (OTCPK:SPHDF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SANNz:UK SANN:Switzerland

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.